Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Exercise or conversion SVP & Cheif Commercial Officer acquired 15,000 shares (option exercise)
  6. 4 Shares withheld for taxes President and CEO gave up 16,836 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, CFO, Sec & Treasurer gave up 6,978 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Open-market sale SVP & Chief Medical Officer sold 4,760 shares at $4.65 ($22,152)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale President and CEO sold 11,350 shares at $4.69 ($53,254)
  20. 4 Open-market sale SVP, CFO, Sec & Treasurer sold 4,920 shares at $4.67 ($22,994)

Page 16 of 29 · 579 filings